NCT05620420已完成不适用
A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 501
- 试验地点
- 1
- 主要终点
- morbidity of psychological distress in patients with multiple myeloma.
研究概览
简要总结
Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with symptomatic multiple myeloma were diagnosed according to the criteria of Chinese multiple myeloma diagnosis and treatment guidelines (revised in 2022).
- •Age ≥18 years, with junior high school education or above. Patients have normal ability of communication and understanding.
- •Informed consent has been signed.
排除标准
- •Who has kinship with other enrolled patients.
- •Life expectancy of< 6 months.
结局指标
主要结局
morbidity of psychological distress in patients with multiple myeloma.
时间窗: Baseline (the time when the patient is enrolled to the study)
The total score of DT scale ≥4 points is defined as obviously psychological distress.
次要结局
- morbidity of anxiety in patients with multiple myeloma.(Baseline (the time when the patient is enrolled to the study))
- morbidity of insomnia in patients with multiple myeloma.(Baseline (the time when the patient is enrolled to the study))
研究者
研究点 (1)
Loading locations...
相似试验
终止
1 期
CT Antigen TCR-Engineered T Cells for MyelomaMultiple MyelomaNCT01892293Adaptimmune6
终止
1 期
A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell LymphomaMultiple Myeloma, RefractoryDiffuse Large B-Cell LymphomaDiffuse Large B Cell Lymphoma RefractoryMultiple Myeloma in RelapseNCT05121103Epizyme, Inc.13
终止
不适用
CAR-T Cells Therapy in Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Multiple Myeloma(MM)NCT03473496Zhujiang Hospital2
已完成
4 期
A Multiple Myeloma Trial in Patients With Bone MetastasesMultiple MyelomaNCT00104104Novartis Pharmaceuticals179
进行中（未招募）
4 期
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMAMultiple MyelomaNCT03829371University of Turin, Italy450